glp-1 review article receptor agonists for individualized treatment of type 2 diabetes mellitus This article examines the potential

Clinical observations have revealed improvements in blood sugar regulation, reductions in liver fat deposits, decreased inflammatory markers, and positive shifts in cardiovascular risk profiles

Semaglutides sales reached $21.2 billion in 2023 with an 88% increase, becoming top 3 best-selling drugs worldwide

To better understand the effects of semaglutide on heart disease, the researchers evaluated the health data of a previous randomized trial that included 17,604 individuals with overweight or obesity and heart disease over the course of 3.5 years

And they are manageable

Exercise : Engage in regular physical activity suited to your abilities